Last reviewed · How we verify

NCT04803500

Simvastatin Around Immediate Implant

Completed Phase 2 Last updated 17 March 2021
What this trial tests

Phase 2 trial testing Simvastatin in Immediate Implant Placement in 10 participants. Completed in 3 May 2016.

Timeline
2 April 2015
Primary endpoint
15 February 2016
3 May 2016

Quick facts

Lead sponsorAin Shams University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment10
Start date2 April 2015
Primary completion15 February 2016
Estimated completion3 May 2016

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 50, any sex, with Immediate Implant Placement or Bone Regeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluated the effect of local application of simvastatin around immediate implant on the amount of gap fill, ridge dimensional alterations and bone density in humans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Simvastatin

Trials testing the same drug.

Other recruiting trials for Immediate Implant Placement

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04803500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing